{
  "id": 5529005,
  "title": "The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels.",
  "url": "https://urgent.news/2026/09/04/the-cancer-vaccine-gold-rush-has-begun-so-has-the-race-for-picks-and",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-04T09:30:00.000Z",
  "source": {
    "name": "WSJ Markets",
    "slug": "wsj-markets",
    "url": "https://www.wsj.com/health/pharma/the-cancer-vaccine-gold-rush-has-begun-so-has-the-race-for-picks-and-shovels-4b0b6d50?mod=rss_markets_main"
  },
  "original_language": "en",
  "account": null,
  "summary": "Tempus AI could capture a lucrative slice of Moderna and Merck’s personalized cancer therapy business, with Personalis at the center of the bet.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}